APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sterile Gamma-Irradiated 70% IPA

Sterile gamma-irradiated 70% isopropyl alcohol (IPA) is gamma-irradiated sterile IPA, which contains 70% USP-grade Isopropanol (Isopropyl Alcohol) and 30% USP-grade purified water.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Sterile gamma-irradiated 70% isopropyl alcohol (IPA) is gamma-irradiated sterile IPA, which contains 70% USP-grade Isopropanol (Isopropyl Alcohol) and 30% USP-grade purified water.

70% isopropyl alcohol is used for disinfection of hands and equipment surface and surgical devices. 70 % isopropyl alcohol solution kills microorganisms by dissolving the plasma membrane of the cell wall. Plasma membrane of gram negative bacteria consist of thin layer of peptidoglycan that easily destroyed by the alcohol.

Selected research

Market Outlook & Growth Opportunities

Global Sterile Gamma-Irradiated 70% IPA Market Outlook and Growth Opportunities 2026

Report ID 173361510427 December 2025190 pages

Choose your research edition.

Industry ResearchSterile Gamma-Irradiated 70% IPA Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Sterile Gamma-Irradiated 70% IPA Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Sterile Gamma-Irradiated 70% IPA Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sterile Gamma-Irradiated 70% IPA Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sterile Gamma-Irradiated 70% IPA Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Sterile gamma-irradiated 70% isopropyl alcohol (IPA) is gamma-irradiated sterile IPA, which contains 70% USP-grade Isopropanol (Isopropyl Alcohol) and 30% USP-grade purified water.

70% isopropyl alcohol is used for disinfection of hands and equipment surface and surgical devices. 70 % isopropyl alcohol solution kills microorganisms by dissolving the plasma membrane of the cell wall. Plasma membrane of gram negative bacteria consist of thin layer of peptidoglycan that easily destroyed by the alcohol.

Currently, STERIS Corporation, Decon Labs, Contec, Veltek Associates, Ecolab, Texwipe, Filtration Group and AGMA Ltd are major manufacturers of this industry. STERIS is the world leader, held a share of 18.89% in global market.

Read the full market overview

This report provides an overview of the global Sterile Gamma-Irradiated 70% IPA market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sterile Gamma-Irradiated 70% IPA and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sterile Gamma-Irradiated 70% IPA sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sterile Gamma-Irradiated 70% IPA market size, projected growth trends, production technologies, key applications, and end-use industries.

Sterile Gamma-Irradiated 70% IPA Segment by Company

STERIS Corporation

Decon Labs

Contec

Veltek Associates

Ecolab

Texwipe

AGMA Ltd

Filtration Group

Sterile Gamma-Irradiated 70% IPA Segment by Type

16 oz Spray Bottle

32 oz Spray Bottle

1 Gallon Bottle

Others

Sterile Gamma-Irradiated 70% IPA Segment by Application

Hospital

Laboratories

Pharmaceutical Cleanrooms

Other

Sterile Gamma-Irradiated 70% IPA Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sterile Gamma-Irradiated 70% IPA status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sterile Gamma-Irradiated 70% IPA market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sterile Gamma-Irradiated 70% IPA significant trends, drivers, influence factors in global and regions.

6. To analyze Sterile Gamma-Irradiated 70% IPA competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sterile Gamma-Irradiated 70% IPA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sterile Gamma-Irradiated 70% IPA and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sterile Gamma-Irradiated 70% IPA.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sterile Gamma-Irradiated 70% IPA market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sterile Gamma-Irradiated 70% IPA industry.

Chapter 3: Detailed analysis of Sterile Gamma-Irradiated 70% IPA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sterile Gamma-Irradiated 70% IPA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sterile Gamma-Irradiated 70% IPA in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sterile Gamma-Irradiated 70% IPA Industry Trends Table 2. Sterile Gamma-Irradiated 70% IPA Industry Drivers Table 3. Sterile Gamma-Irradiated 70% IPA Industry Opportunities and Challenges Table 4. Sterile Gamma-Irradiated 70% IPA Industry Restraints Table 5. Global Sterile Gamma-Irradiated 70% IPA Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sterile Gamma-Irradiated 70% IPA Revenue Share by Company (2021-2026) Table 7. Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Company (K Liters) & (2021-2026) Table 8. Global Sterile Gamma-Irradiated 70% IPA Sales Volume Share by Company (2021-2026) Table 9. Global Sterile Gamma-Irradiated 70% IPA Average Price (USD/Liter) of Company (2021-2026) Table 10. Global Sterile Gamma-Irradiated 70% IPA Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sterile Gamma-Irradiated 70% IPA Key Company Manufacturing Base & Headquarters Table 12. Global Sterile Gamma-Irradiated 70% IPA Company, Product Type & Application Table 13. Global Sterile Gamma-Irradiated 70% IPA Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sterile Gamma-Irradiated 70% IPA by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 16 oz Spray Bottle Table 18. Significant Companies of 32 oz Spray Bottle Table 19. Significant Companies of 1 Gallon Bottle Table 20. Significant Companies of Others Table 21. Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Type 2021 VS 2025 VS 2032 (K Liters) Table 22. Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Type (2021-2026) & (K Liters) Table 23. Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Type (2027-2032) & (K Liters) Table 24. Global Sterile Gamma-Irradiated 70% IPA Sales Volume Share by Type (2021-2026) Table 25. Global Sterile Gamma-Irradiated 70% IPA Sales Volume Share by Type (2027-2032) Table 26. Global Sterile Gamma-Irradiated 70% IPA Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Sterile Gamma-Irradiated 70% IPA Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Sterile Gamma-Irradiated 70% IPA Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type (2021-2026) Table 30. Global Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Laboratories Table 33. Significant Companies of Pharmaceutical Cleanrooms Table 34. Significant Companies of Other Table 35. Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Application 2021 VS 2025 VS 2032 (K Liters) Table 36. Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Application (2021-2026) & (K Liters) Table 37. Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Application (2027-2032) & (K Liters) Table 38. Global Sterile Gamma-Irradiated 70% IPA Sales Volume Share by Application (2021-2026) Table 39. Global Sterile Gamma-Irradiated 70% IPA Sales Volume Share by Application (2027-2032) Table 40. Global Sterile Gamma-Irradiated 70% IPA Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Sterile Gamma-Irradiated 70% IPA Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Sterile Gamma-Irradiated 70% IPA Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application (2021-2026) Table 44. Global Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application (2027-2032) Table 45. Global Sterile Gamma-Irradiated 70% IPA Sales by Region: 2021 VS 2025 VS 2032 (K Liters) Table 46. Global Sterile Gamma-Irradiated 70% IPA Sales by Region (2021-2026) & (K Liters) Table 47. Global Sterile Gamma-Irradiated 70% IPA Sales Market Share by Region (2021-2026) Table 48. Global Sterile Gamma-Irradiated 70% IPA Sales by Region (2027-2032) & (K Liters) Table 49. Global Sterile Gamma-Irradiated 70% IPA Sales Market Share by Region (2027-2032) Table 50. Global Sterile Gamma-Irradiated 70% IPA Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Sterile Gamma-Irradiated 70% IPA Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Sterile Gamma-Irradiated 70% IPA Sales Value Share by Region (2021-2026) Table 53. Global Sterile Gamma-Irradiated 70% IPA Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Sterile Gamma-Irradiated 70% IPA Sales Value Share by Region (2027-2032) Table 55. Global Sterile Gamma-Irradiated 70% IPA Market Average Price (USD/Liter) by Region (2021-2026) Table 56. Global Sterile Gamma-Irradiated 70% IPA Market Average Price (USD/Liter) by Region (2027-2032) Table 57. Global Sterile Gamma-Irradiated 70% IPA Sales by Country: 2021 VS 2025 VS 2032 (K Liters) Table 58. Global Sterile Gamma-Irradiated 70% IPA Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Sterile Gamma-Irradiated 70% IPA Sales by Country (2021-2026) & (K Liters) Table 60. Global Sterile Gamma-Irradiated 70% IPA Sales Market Share by Country (2021-2026) Table 61. Global Sterile Gamma-Irradiated 70% IPA Sales by Country (2027-2032) & (K Liters) Table 62. Global Sterile Gamma-Irradiated 70% IPA Sales Market Share by Country (2027-2032) Table 63. Global Sterile Gamma-Irradiated 70% IPA Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Sterile Gamma-Irradiated 70% IPA Sales Value Market Share by Country (2021-2026) Table 65. Global Sterile Gamma-Irradiated 70% IPA Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Sterile Gamma-Irradiated 70% IPA Sales Value Market Share by Country (2027-2032) Table 67. STERIS Corporation Company Information Table 68. STERIS Corporation Business Overview Table 69. STERIS Corporation Sterile Gamma-Irradiated 70% IPA Sales (K Liters), Value (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 70. STERIS Corporation Sterile Gamma-Irradiated 70% IPA Product Portfolio Table 71. STERIS Corporation Recent Development Table 72. Decon Labs Company Information Table 73. Decon Labs Business Overview Table 74. Decon Labs Sterile Gamma-Irradiated 70% IPA Sales (K Liters), Value (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 75. Decon Labs Sterile Gamma-Irradiated 70% IPA Product Portfolio Table 76. Decon Labs Recent Development Table 77. Contec Company Information Table 78. Contec Business Overview Table 79. Contec Sterile Gamma-Irradiated 70% IPA Sales (K Liters), Value (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 80. Contec Sterile Gamma-Irradiated 70% IPA Product Portfolio Table 81. Contec Recent Development Table 82. Veltek Associates Company Information Table 83. Veltek Associates Business Overview Table 84. Veltek Associates Sterile Gamma-Irradiated 70% IPA Sales (K Liters), Value (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 85. Veltek Associates Sterile Gamma-Irradiated 70% IPA Product Portfolio Table 86. Veltek Associates Recent Development Table 87. Ecolab Company Information Table 88. Ecolab Business Overview Table 89. Ecolab Sterile Gamma-Irradiated 70% IPA Sales (K Liters), Value (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 90. Ecolab Sterile Gamma-Irradiated 70% IPA Product Portfolio Table 91. Ecolab Recent Development Table 92. Texwipe Company Information Table 93. Texwipe Business Overview Table 94. Texwipe Sterile Gamma-Irradiated 70% IPA Sales (K Liters), Value (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 95. Texwipe Sterile Gamma-Irradiated 70% IPA Product Portfolio Table 96. Texwipe Recent Development Table 97. AGMA Ltd Company Information Table 98. AGMA Ltd Business Overview Table 99. AGMA Ltd Sterile Gamma-Irradiated 70% IPA Sales (K Liters), Value (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 100. AGMA Ltd Sterile Gamma-Irradiated 70% IPA Product Portfolio Table 101. AGMA Ltd Recent Development Table 102. Filtration Group Company Information Table 103. Filtration Group Business Overview Table 104. Filtration Group Sterile Gamma-Irradiated 70% IPA Sales (K Liters), Value (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 105. Filtration Group Sterile Gamma-Irradiated 70% IPA Product Portfolio Table 106. Filtration Group Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Sterile Gamma-Irradiated 70% IPA Distributors List Table 110. Sterile Gamma-Irradiated 70% IPA Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Sterile Gamma-Irradiated 70% IPA Product Image Figure 2. Global Sterile Gamma-Irradiated 70% IPA Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sterile Gamma-Irradiated 70% IPA Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sterile Gamma-Irradiated 70% IPA Sales (2021-2032) & (K Liters) Figure 5. Global Sterile Gamma-Irradiated 70% IPA Sales Average Price (USD/Liter) & (2021-2032) Figure 6. Global Sterile Gamma-Irradiated 70% IPA Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 16 oz Spray Bottle Image Figure 10. 32 oz Spray Bottle Image Figure 11. 1 Gallon Bottle Image Figure 12. Others Image Figure 13. Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Type (2021 VS 2025 VS 2032) & (K Liters) Figure 14. Global Sterile Gamma-Irradiated 70% IPA Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Sterile Gamma-Irradiated 70% IPA Sales Volume Share by Type (2021-2032) Figure 16. Global Sterile Gamma-Irradiated 70% IPA Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Sterile Gamma-Irradiated 70% IPA Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Laboratories Image Figure 21. Pharmaceutical Cleanrooms Image Figure 22. Other Image Figure 23. Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Application (2021 VS 2025 VS 2032) & (K Liters) Figure 24. Global Sterile Gamma-Irradiated 70% IPA Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Sterile Gamma-Irradiated 70% IPA Sales Volume Share by Application (2021-2032) Figure 26. Global Sterile Gamma-Irradiated 70% IPA Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Sterile Gamma-Irradiated 70% IPA Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application (2021-2032) Figure 29. Global Sterile Gamma-Irradiated 70% IPA Sales by Region: 2021 VS 2025 VS 2032 (K Liters) Figure 30. Global Sterile Gamma-Irradiated 70% IPA Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Sterile Gamma-Irradiated 70% IPA Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Sterile Gamma-Irradiated 70% IPA Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Sterile Gamma-Irradiated 70% IPA Sales Value (2021-2032) & (US$ Million) Figure 34. North America Sterile Gamma-Irradiated 70% IPA Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Sterile Gamma-Irradiated 70% IPA Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Sterile Gamma-Irradiated 70% IPA Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Sterile Gamma-Irradiated 70% IPA Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Sterile Gamma-Irradiated 70% IPA Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Sterile Gamma-Irradiated 70% IPA Sales Value (2021-2032) & (US$ Million) Figure 40. South America Sterile Gamma-Irradiated 70% IPA Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Sterile Gamma-Irradiated 70% IPA Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Sterile Gamma-Irradiated 70% IPA Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Sterile Gamma-Irradiated 70% IPA Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Sterile Gamma-Irradiated 70% IPA Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • 16 oz Spray Bottle
  • 32 oz Spray Bottle
  • 1 Gallon Bottle
  • Others
Applications
  • Hospital
  • Laboratories
  • Pharmaceutical Cleanrooms
  • Other
Companies covered
  • STERIS Corporation
  • Decon Labs
  • Contec
  • Veltek Associates
  • Ecolab
  • Texwipe
  • AGMA Ltd
  • Filtration Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sterile Gamma-Irradiated 70% IPA Sales Value (2021-2032)
  4. 1.2.2 Global Sterile Gamma-Irradiated 70% IPA Sales Volume (2021-2032)
  5. 1.2.3 Global Sterile Gamma-Irradiated 70% IPA Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sterile Gamma-Irradiated 70% IPA Market Dynamics
  1. 2.1 Sterile Gamma-Irradiated 70% IPA Industry Trends
  2. 2.2 Sterile Gamma-Irradiated 70% IPA Industry Drivers
  3. 2.3 Sterile Gamma-Irradiated 70% IPA Industry Opportunities and Challenges
  4. 2.4 Sterile Gamma-Irradiated 70% IPA Industry Restraints
3 Sterile Gamma-Irradiated 70% IPA Market by Company
  1. 3.1 Global Sterile Gamma-Irradiated 70% IPA Company Revenue Ranking in 2025
  2. 3.2 Global Sterile Gamma-Irradiated 70% IPA Revenue by Company (2021-2026)
  3. 3.3 Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Company (2021-2026)
  4. 3.4 Global Sterile Gamma-Irradiated 70% IPA Average Price by Company (2021-2026)
  5. 3.5 Global Sterile Gamma-Irradiated 70% IPA Company Ranking (2024-2026)
  6. 3.6 Global Sterile Gamma-Irradiated 70% IPA Company Manufacturing Base and Headquarters
  7. 3.7 Global Sterile Gamma-Irradiated 70% IPA Company Product Type and Application
  8. 3.8 Global Sterile Gamma-Irradiated 70% IPA Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sterile Gamma-Irradiated 70% IPA Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sterile Gamma-Irradiated 70% IPA Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sterile Gamma-Irradiated 70% IPA Market by Type
  1. 4.1 Sterile Gamma-Irradiated 70% IPA Type Introduction
  2. 4.1.1 16 oz Spray Bottle
  3. 4.1.2 32 oz Spray Bottle
  4. 4.1.3 1 Gallon Bottle
  5. 4.1.4 Others
  6. 4.2 Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Type
  7. 4.2.1 Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Sterile Gamma-Irradiated 70% IPA Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Sterile Gamma-Irradiated 70% IPA Sales Value by Type
  11. 4.3.1 Global Sterile Gamma-Irradiated 70% IPA Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Sterile Gamma-Irradiated 70% IPA Sales Value by Type (2021-2032)
  13. 4.3.3 Global Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type (2021-2032)
5 Sterile Gamma-Irradiated 70% IPA Market by Application
  1. 5.1 Sterile Gamma-Irradiated 70% IPA Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Laboratories
  4. 5.1.3 Pharmaceutical Cleanrooms
  5. 5.1.4 Other
  6. 5.2 Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Application
  7. 5.2.1 Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Sterile Gamma-Irradiated 70% IPA Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Sterile Gamma-Irradiated 70% IPA Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Sterile Gamma-Irradiated 70% IPA Sales Value by Application
  11. 5.3.1 Global Sterile Gamma-Irradiated 70% IPA Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Sterile Gamma-Irradiated 70% IPA Sales Value by Application (2021-2032)
  13. 5.3.3 Global Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application (2021-2032)
6 Sterile Gamma-Irradiated 70% IPA Regional Sales and Value Analysis
  1. 6.1 Global Sterile Gamma-Irradiated 70% IPA Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sterile Gamma-Irradiated 70% IPA Sales by Region (2021-2032)
  3. 6.2.1 Global Sterile Gamma-Irradiated 70% IPA Sales by Region: 2021-2026
  4. 6.2.2 Global Sterile Gamma-Irradiated 70% IPA Sales by Region (2027-2032)
  5. 6.3 Global Sterile Gamma-Irradiated 70% IPA Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sterile Gamma-Irradiated 70% IPA Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sterile Gamma-Irradiated 70% IPA Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sterile Gamma-Irradiated 70% IPA Sales Value by Region (2027-2032)
  9. 6.5 Global Sterile Gamma-Irradiated 70% IPA Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sterile Gamma-Irradiated 70% IPA Sales Value (2021-2032)
  12. 6.6.2 North America Sterile Gamma-Irradiated 70% IPA Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sterile Gamma-Irradiated 70% IPA Sales Value (2021-2032)
  15. 6.7.2 Europe Sterile Gamma-Irradiated 70% IPA Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sterile Gamma-Irradiated 70% IPA Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sterile Gamma-Irradiated 70% IPA Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sterile Gamma-Irradiated 70% IPA Sales Value (2021-2032)
  21. 6.9.2 South America Sterile Gamma-Irradiated 70% IPA Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sterile Gamma-Irradiated 70% IPA Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sterile Gamma-Irradiated 70% IPA Sales Value Share by Country, 2025 VS 2032
7 Sterile Gamma-Irradiated 70% IPA Country-level Sales and Value Analysis
  1. 7.1 Global Sterile Gamma-Irradiated 70% IPA Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sterile Gamma-Irradiated 70% IPA Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sterile Gamma-Irradiated 70% IPA Sales by Country (2021-2032)
  4. 7.3.1 Global Sterile Gamma-Irradiated 70% IPA Sales by Country (2021-2026)
  5. 7.3.2 Global Sterile Gamma-Irradiated 70% IPA Sales by Country (2027-2032)
  6. 7.4 Global Sterile Gamma-Irradiated 70% IPA Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sterile Gamma-Irradiated 70% IPA Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sterile Gamma-Irradiated 70% IPA Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sterile Gamma-Irradiated 70% IPA Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sterile Gamma-Irradiated 70% IPA Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sterile Gamma-Irradiated 70% IPA Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 STERIS Corporation
  2. 8.1.1 STERIS Corporation Company Information
  3. 8.1.2 STERIS Corporation Business Overview
  4. 8.1.3 STERIS Corporation Sterile Gamma-Irradiated 70% IPA Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 STERIS Corporation Sterile Gamma-Irradiated 70% IPA Product Portfolio
  6. 8.1.5 STERIS Corporation Recent Developments
  7. 8.2 Decon Labs
  8. 8.2.1 Decon Labs Company Information
  9. 8.2.2 Decon Labs Business Overview
  10. 8.2.3 Decon Labs Sterile Gamma-Irradiated 70% IPA Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Decon Labs Sterile Gamma-Irradiated 70% IPA Product Portfolio
  12. 8.2.5 Decon Labs Recent Developments
  13. 8.3 Contec
  14. 8.3.1 Contec Company Information
  15. 8.3.2 Contec Business Overview
  16. 8.3.3 Contec Sterile Gamma-Irradiated 70% IPA Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Contec Sterile Gamma-Irradiated 70% IPA Product Portfolio
  18. 8.3.5 Contec Recent Developments
  19. 8.4 Veltek Associates
  20. 8.4.1 Veltek Associates Company Information
  21. 8.4.2 Veltek Associates Business Overview
  22. 8.4.3 Veltek Associates Sterile Gamma-Irradiated 70% IPA Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Veltek Associates Sterile Gamma-Irradiated 70% IPA Product Portfolio
  24. 8.4.5 Veltek Associates Recent Developments
  25. 8.5 Ecolab
  26. 8.5.1 Ecolab Company Information
  27. 8.5.2 Ecolab Business Overview
  28. 8.5.3 Ecolab Sterile Gamma-Irradiated 70% IPA Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ecolab Sterile Gamma-Irradiated 70% IPA Product Portfolio
  30. 8.5.5 Ecolab Recent Developments
  31. 8.6 Texwipe
  32. 8.6.1 Texwipe Company Information
  33. 8.6.2 Texwipe Business Overview
  34. 8.6.3 Texwipe Sterile Gamma-Irradiated 70% IPA Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Texwipe Sterile Gamma-Irradiated 70% IPA Product Portfolio
  36. 8.6.5 Texwipe Recent Developments
  37. 8.7 AGMA Ltd
  38. 8.7.1 AGMA Ltd Company Information
  39. 8.7.2 AGMA Ltd Business Overview
  40. 8.7.3 AGMA Ltd Sterile Gamma-Irradiated 70% IPA Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 AGMA Ltd Sterile Gamma-Irradiated 70% IPA Product Portfolio
  42. 8.7.5 AGMA Ltd Recent Developments
  43. 8.8 Filtration Group
  44. 8.8.1 Filtration Group Company Information
  45. 8.8.2 Filtration Group Business Overview
  46. 8.8.3 Filtration Group Sterile Gamma-Irradiated 70% IPA Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Filtration Group Sterile Gamma-Irradiated 70% IPA Product Portfolio
  48. 8.8.5 Filtration Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sterile Gamma-Irradiated 70% IPA Value Chain Analysis
  2. 9.1.1 Sterile Gamma-Irradiated 70% IPA Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sterile Gamma-Irradiated 70% IPA Sales Mode & Process
  6. 9.2 Sterile Gamma-Irradiated 70% IPA Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sterile Gamma-Irradiated 70% IPA Distributors
  9. 9.2.3 Sterile Gamma-Irradiated 70% IPA Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst